OrthoTrophix Presents Evidence for Disease Modification in Knee Osteoarthritis by TPX-100 at American College of Rheumatology Annual Meeting

Credit: Business Wire- Published on November 9, 2019
OAKLAND, Calif.--(BUSINESS WIRE)--Clinical improvements in knee osteoarthritis by TPX-100 treatment were linked to significant reduction of pathological bone shape change.

You are here

You might like